Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
It looks like the content you intended for me to summarize didn't come through. Could you paste the text? Once I have it, I'll return the summary exactly as specified, without additional commentary.
Alkaline phosphatase (ALP) is an enzyme found throughout your body, especially in the liver, bones and intestines. When ALP levels fall abnormally low—a condition often called low alkp—you may notice trouble with movement, bone pain or muscle weakness. Understanding why crashing enzyme counts affect your mobility can help you take the right steps toward diagnosis and treatment.
When ALP dips below the expected range, the body can’t maintain its usual repair and maintenance processes. Over time, this may lead to:
If you’ve had routine blood work showing low alkp, ask your doctor about these potential triggers.
Although low alkp itself is a lab finding, watch for these warning signs that movement may be at risk:
If you experience any of the above, it’s time to dig deeper.
When you present with low alkp and movement issues, a physician will usually follow these steps:
These steps help pinpoint the exact cause of low alkp and the severity of its impact on your bones and muscles.
Treatment depends on the underlying cause of low alkp. Common approaches include:
Low alkp alone isn’t usually an emergency. However, contact your doctor right away if you experience:
For a quick check of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Remember, catching and addressing low alkp early helps protect your bones and keeps you moving comfortably.
Important: If you have serious or life-threatening symptoms, speak to a doctor or visit the nearest emergency department immediately. Always consult a healthcare professional before starting any new supplement or treatment plan.
(References)
* Clark GT, Ram S. Orofacial Movement Disorders. Oral Maxillofac Surg Clin North Am. 2016 Aug;28(3):397-407. doi: 10.1016/j.coms.2016.03.003. PMID: 27475514.
* Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy. J Neuroimmunol. 2019 Jul 15;332:91-98. doi: 10.1016/j.jneuroim.2019.04.004. 2019 Apr 9. PMID: 30991306.
* Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA, Gradinaru V. Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020 Mar;23(3):327-336. doi: 10.1038/s41593-020-0589-7. 2020 Feb 17. PMID: 32066981; PMCID: PMC7065967.
* Tanner CM, Ostrem JL. Therapeutic Advances in Movement Disorders. Neurotherapeutics. 2020 Oct;17(4):1325-1330. doi: 10.1007/s13311-020-00988-2. 2021 Jan 15. PMID: 33452629; PMCID: PMC7810426.
* González-Rodríguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA, Wokosin DL, Gao L, Kaplitt MG, López-Barneo J, Schumacker PT, Surmeier DJ. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature. 2021 Nov;599(7886):650-656. doi: 10.1038/s41586-021-04059-0. 2021 Nov 3. PMID: 34732887; PMCID: PMC9189968.
* Pérez-Dueñas B, Gorman K, Marcé-Grau A, Ortigoza-Escobar JD, Macaya A, Danti FR, Barwick K, Papandreou A, Ng J, Meyer E, Mohammad SS, Smith M, Muntoni F, Munot P, Uusimaa J, Vieira P, Sheridan E, Guerrini R, Cobben J, Yilmaz S, De Grandis E, Dale RC, Pons R, Peall KJ, Leuzzi V, Kurian MA. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders. Mov Disord. 2022 Nov;37(11):2197-2209. doi: 10.1002/mds.29182. 2022 Aug 25. PMID: 36054588; PMCID: PMC9804670.
* Jennings D, Huntwork-Rodriguez S, Vissers MFJM, Daryani VM, Diaz D, Goo MS, Chen JJ, Maciuca R, Fraser K, Mabrouk OS, van de Wetering de Rooij J, Heuberger JAAC, Groeneveld GJ, Borin MT, Cruz-Herranz A, Graham D, Scearce-Levie K, De Vicente J, Henry AG, Chin P, Ho C, Troyer MD. LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Mov Disord. 2023 Mar;38(3):386-398. doi: 10.1002/mds.29297. 2023 Feb 18. PMID: 36807624.
* Mumoli L, Magro G, Bosco D. Footloose (footloose), footloose. Neurol Sci. 2024 Feb;45(2):825-826. doi: 10.1007/s10072-023-07112-0. 2023 Oct 13. PMID: 37828390.
* Tolonen JP, Parolin Schnekenberg R, McGowan S, Sims D, McEntagart M, Elmslie F, Shears D, Stewart H, Tofaris GK, Dabir T, Morrison PJ, Johnson D, Hadjivassiliou M, Ellard S, Shaw-Smith C, Znaczko A, Dixit A, Suri M, Sarkar A, Harrison RE, Jones G, Houlden H, Ceravolo G, Jarvis J, Williams J, Shanks ME, Clouston P, Rankin J, Blumkin L, Lerman-Sagie T, Ponger P, Raskin S, Granath K, Uusimaa J, Conti H, McCann E, Joss S, Blakes AJM, Metcalfe K, Kingston H, Bertoli M, Kneen R, Lynch SA, Martínez Albaladejo I, Moore AP, Jones WD, Genomics England Research Consortium, Becker EBE, Németh AH. Detailed Analysis of ITPR1 Missense Variants Guides Diagnostics and Therapeutic Design. Mov Disord. 2024 Jan;39(1):141-151. doi: 10.1002/mds.29651. 2023 Nov 14. PMID: 37964426; PMCID: PMC10952845.
* Rossi M, Schaake S, Usnich T, Boehm J, Steffen N, Schell N, Krüger C, Gül-Demirkale T, Bahr N, Kleinz T, Madoev H, Laabs BH, Gan-Or Z, Alcalay RN, Lohmann K, Klein C. Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review. Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. 2025 Feb 10. PMID: 39927608; PMCID: PMC12006889.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.